Citation

Mann JJ. Cell Rep. Med. 2023; 4(1): e100906.

Copyright

(Copyright © 2023, Cell Press)

DOI

10.1016/j.xcrm.2022.100906

PMID

36652915

PMCID

PMC9873942

Abstract

Goodwin et al.(1) report a single 25 mg dose of psilocybin has an antidepressant effect short-term in medication-resistant depression. Unanswered questions include drug blood level as a guide to dose, psychedelic effects relationship to antidepressant benefit, and potential suicide risk of psilocybin.

Language: en

Keywords

*Hallucinogens/pharmacology/therapeutic use; *Psilocybin/pharmacology/therapeutic use; Antidepressive Agents/adverse effects; Humans